Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Advanced Micro Devices said on Tuesday it agreed to sell as much as $60 billion in artificial intelligence chips to Meta Platforms over five years, in a deal that also gives Meta the option to acquire up to a 10% stake in the chipmaker. The arrangement follows a similar agreement AMD signed last year with OpenAI and is being read by analysts as ano…
Amy Rochelle Davis, vice president and president of Accelera and Communications at Cummins Inc. (CMI), sold 1,863 shares of common stock on February 23, 2026, generating proceeds of $1,093,504. The disposition was disclosed alongside the company’s fourth-quarter results, which showed adjusted earnings per share of $5.81, EBITDA of $1.4 billion, and…
MacroGenics Inc (NASDAQ: MGNX) saw its stock decline 7.4% in premarket trading after the U.S. Food and Drug Administration placed a partial clinical hold on the LINNET study of lorigerlimab in gynecologic cancer patients. The hold stops new patient enrollment, while allowing those already dosed to continue receiving the investigational drug. The ac…
The White House reiterated that diplomacy is President Trump's first option in dealings with Iran, while also stressing his willingness to employ lethal U.S. military force if required. The comment came as U.S. Secretary of State Marco Rubio prepares to brief top congressional leaders on Iran, and as a significant U.S. naval presence has been posit…
Bank of America told clients that Arm Holdings is well positioned to capture a larger slice of the expanding AI inference market as central processing units play a growing role in data-center workloads. The bank raised its price target on Arm and updated its long-term CPU share outlook while reiterating a Neutral rating.
Larimar Therapeutics saw a sharp premarket gain after the FDA awarded Breakthrough Therapy Designation to nomlabofusp for Friedreich's ataxia, citing preliminary open-label data showing increased skin frataxin and directional improvement across multiple clinical outcomes. The company and the agency remain aligned on key endpoints and analyses as La…
JPMorgan upgraded Domino's Pizza from Neutral to Overweight and set a $450 price target, pointing to consistent share gains, a resilient franchise-heavy business, and visible international expansion as reasons to buy around current levels. The bank emphasized steady U.S. unit growth, strong carryout sales and a cost-efficient delivery network while…
Federal Reserve Governor Christopher Waller said the U.S. central bank is taking a careful, coordinated approach to adopting artificial intelligence, stressing robust security, model validation and human accountability. Speaking at a Federal Reserve Bank of Boston conference, Waller outlined specific guardrails and said the Fed will align system-wi…
Morgan Stanley reduced its 12-month price target on JBS SA to $20.50 from $21.00 yet retained an Overweight rating. The bank expects a resilient fourth quarter of fiscal 2025 with EBITDA in line with consensus, sees solid performance across key divisions, and projects meaningful free cash flow in 2026. Separately, JBS is closing a U.S. beef facilit…
Piper Sandler reduced its price target for Beyond Inc (NYSE:BBYY) to $8 from $10 while retaining a Neutral rating, pointing to uncertainty around the integration of the company’s three business pillars. The research firm acknowledged sequential improvement in core operations during the fourth quarter but noted a 10% year-over-year revenue decline. …
KeyBanc has increased its 12-month price objective for Welltower Inc. (WELL) to $240 from $210 and kept an Overweight rating, signaling confidence in the company's positioning in the private-pay senior housing operating portfolio. The brokerage highlights aging demographics, limited new supply and management's data-focused operating model as cataly…
KeyBanc has maintained a Sector Weight rating on Hims & Hers Health Inc. following the company's fourth-quarter results and its 2026 revenue guidance. The firm judged the top-line outcomes and the 2026 revenue outlook to be largely in line with expectations, while noting planned increased investment to scale new initiatives and international ex…
Monte Rosa Therapeutics saw its shares rise in premarket trading after presenting Phase 1/2 data for MRT-2359 combined with enzalutamide in metastatic castration-resistant prostate cancer. The data showed complete PSA responses and disease control in a small AR-mutant subgroup and a broader RECIST disease control rate across evaluable patients, wit…
Keefe, Bruyette & Woods maintained an Outperform rating and a $363.00 price target on JPMorgan Chase & Co., citing the bank’s global franchise, leadership in KBW rankings, and a reaffirmed through-the-cycle return on tangible common equity target of 17%. The firm projects JPMorgan will exceed that target by about 300 basis points in 2026 and 2027 a…
Bernstein SocGen Group maintained a Market Perform rating and a $45 price target on PayPal Holdings Inc. following media reports that the company has drawn takeover interest. The firm highlighted sum-of-the-parts valuation prospects for PayPal's businesses after a steep share-price decline, while other analysts and corporate developments have added…
Bernstein SocGen raised its price target on Warner Bros. Discovery to $27.75 from $23.50 while keeping a Market Perform rating. The firm notes the Netflix cash offer underpins the new target as a likely floor for a potential transaction, and identifies Linear EBITDA as the key figure to monitor in the imminent fourth-quarter report. Market particip…
Keefe, Bruyette & Woods increased its price target on Lemonade Inc. to $44 from $40 following the insurer’s stronger-than-expected fourth-quarter results. Despite the higher target, the firm kept an Underperform rating, citing competition, potential AI disruption in personal lines, and the difficulty of sustaining rapid growth alongside low loss ra…
A coalition of travel industry representatives and lawmakers urged the Trump administration on Feb. 24 to promptly restore Global Entry, the trusted-traveler program that speeds U.S. customs and immigration processing for pre-approved, low-risk international arrivals. The Department of Homeland Security suspended the program on Sunday but chose not…
MiniMed Group, the diabetes business spun out of Medtronic, filed to raise up to $784 million in an initial public offering, proposing to sell 28 million shares at $25 to $28 each. The filing outlines the unit’s recent financials, product mix, global footprint, and the extent of Medtronic’s retained voting power.
Yahoo Finance has formed a partnership with Coinbase to enable users to move from crypto and equity tickers on Yahoo's site directly to Coinbase to execute trades. The agreement includes integration of Coinbase data and insights into Yahoo Finance, a promotional one-month Coinbase One offer for users, and plans for deeper ties between Yahoo Finance…
Bernstein SocGen Group reaffirmed an Outperform rating and a $160 price target on Gilead Sciences after the company's acquisition of Arcellx. The transaction, valued at an implied $7.8 billion equity price, includes cash and a contingent value right tied to sales milestones and is positioned to strengthen Gilead’s CAR-T capabilities within its Kite…
Itau BBA reaffirmed an Outperform rating and a $20.00 price target on Nu Holdings (NYSE: NU), arguing that the Brazilian digital bank is positioned to benefit from artificial intelligence-driven changes in financial services. The bank pointed to recent revenue growth of 20% over the last year and a return on equity of 28%, and described Nubank as a…
Bernstein SocGen Group has reaffirmed an Outperform rating on Paccar Inc. with a $138.00 price target, implying roughly 9% upside from the current price of $126.06. The research note highlights benefits from Section 232-related changes favoring domestic production, a parts strategy that could materially boost earnings, and enhanced manufacturing fl…
Bernstein SocGen Group maintained an Outperform rating and a $39.00 price target for StandardAero Inc (SARO) while updating its model ahead of the company's fourth-quarter 2025 earnings. The analyst note incorporates revised 2025 guidance tied to a secondary share offering and highlights growth in key engine programs that should support margins and…
A World Bank report finds a substantial divide between laws designed to secure women’s economic rights and the enforcement mechanisms and institutions needed to make those laws effective. Although many countries have updated legal frameworks, enforcement and supportive systems lag, leaving less than 5% of women in economies approaching full legal e…
